Brief: Rain Enhancement Technologies Holdco Inc - Q1 And Q2 2025 Financial Statements Should Not Be Relied Upon Due To Accounting Error - SEC Filing
14/04/2026 21:26
April 14 (Reuters) - Rain Enhancement Technologies Holdco Inc RAIN.O: RAIN ENHANCEMENT TECHNOLOGIES HOLDCO INC - Q1 AND Q2 2025 FINANCIAL STATEMENTS SHOULD NOT BE RELIED UPON DUE TO ACCOUNTING ERROR - SEC FILING RAIN ENHANCEMENT TECHNOLOGIES HOLDCO INC - TO RESTATE FINANCIAL STATEMENTS FOR Q1 AND Q2 2025 - SEC FILING RAIN ENHANCEMENT TECHNOLOGIES HOLDCO INC - ERROR ONLY AFFECTED BALANCE SHEETS, NO IMPACT ON OPERATIONS OR CASH FLOWS - SEC FILING RAIN ENHANCEMENT TECHNOLOGIES HOLDCO INC - TO REPORT MATERIAL WEAKNESSES IN INTERNAL CONTROL AS OF DEC 31, 2025 - SEC FILING Source text: [] Further company coverage: RAIN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rain Oncology
See all newsBrief: Rain Enhancement Technologies Holdco - May Offer Up To $25 Million In Securities From Time To Time - SEC Filing
Brief: Rain Enhancement Technologies Holdco Inc - Q1 And Q2 2025 Financial Statements Should Not Be Relied Upon Due To Accounting Error - SEC Filing
Brief: Rain Oncology Pursuant To Proposed Deal With Pathos AI
Brief: Rain Oncology To Be Acquired By Pathos AI For $1.16 In Cash Per Share Plus Contingent Value Rights
Brief: Rain Oncology Q3 Net Income USD -7.034 Million